Your Source for Venture Capital and Private Equity Financings

Ancora Heart Secures $80M Financing

2021-07-20
SANTA CLARA, CA, Ancora Heart, a company developing a novel therapy to address heart failure, has closed an $80 million equity financing.
SANTA CLARA, CA, Ancora Heart, a company developing a novel therapy to address heart failure, has closed an $80 million equity financing. Sands Capital, Sio Capital and an undisclosed strategic investor joined all existing investors in this financing.

Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company's proprietary AccuCinch Ventricular Restoration System is the only completely transcatheter device designed to restore the structure and function of the enlarged left ventricle of the heart.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors